AUTISM FIRST STEPS
AUTISM DAILY NEWSLETTER
Saturday, November 24, 2001
INDEX:
* Quote from Chair of President Bush's Commission on Special
Education
* Effective Treatment for
ADHD
* Major Stress During Pregnancy Linked To Autism
* MAJOR STRESS DURING
PREGNANCY LINKED TO AUTISM
* Melatonin May Treat Side Effects of Antipsychotics
******************************
Quote from Chair of President
Bush's Commission on Special Education
Gov. Branstad (former governor of
Iowa) has been appointed to serve as
chair of the Administration's new special education commission.
Following is a quote from Gov Branstad (Iowa) from an interview
transcript. The entire transcript is available at:
http://www.pbs.org/newshour/bb/education/schools_1-16.html
GOV. TERRY BRANSTAD: In our
state nearly 60 percent of the budget goes
for education. And what we find is people are willing to invest in
quality education, but they are also fiscally conservative. They want to
see results. They want to see achievement for the dollars that they put
in. I think that the federal government in its mandates in the area of
special ed has driven up costs needlessly. I think that needs to be
reviewed. I want to see every child have an opportunity to learn. All
special ed children do have a right to an education, but to spend tens
oft housands of dollars on kids that really are not going to be able to
support themselves or be able to really learn a great deal at the
expense of the general education of the rest of the students is not
fair. And so that has to be addressed. A lot of people are afraid of it,
of being, you know, accused of being insensitive or whatever. I was in
Sioux City,Iowa, yesterday, and I heard from a Teacher of the Year,
Nancy Mounts,who had been Teacher of the Year, and the superintendent
there about how their school is being squeezed because of the federal mandates
in the area of special ed and how there needs to be more flexibility and
latitude given to local school districts in that area.
******************************
Effective Treatment for ADHD
Martin L. Korn, MD
Introduction
Attention-deficit/hyperactivity
disorder (ADHD) is one of the most frequently diagnosed psychiatric disorders
in children. Extensive research in many different populations has found many
significant risks associated with the syndrome. The rates of difficulties, such
as low educational level, substance abuse, and criminal behavior are high in
this population and their effects may persist into adulthood.[1,2] Fortunately, a wide array of drugs are available to
effectively treat the disorder.[3,4] Furthermore, intensive media coverage has increased the
public's awareness about this disorder. Despite these positive factors, the
rate of effective diagnosis and treatment of ADHD remains suboptimal. Regina
Bussing, MD,[5] from the University of Florida, Gainesville, has been
investigating the multiple barriers impeding the proper treatment of
ADHD.Inequality of Service Delivery
In addition to problems in the diagnosis
and treatment of ADHD, there is evidence that there are inequalities in the
administration of services. It would be expected that the services for males
would be greater than females considering the 2:1 male to female prevalence.
However, there is evidence that ADHD is underdiagnosed in girls at a rate well
above this difference in prevalence rates. In a recent study, Bussing and
colleagues[6] screened children in the second through
fourth grades who were enrolled in a special education program. Only half of
the children diagnosed with ADHD were receiving treatment, and it was estimated
that the girls were underserved at a rate 3 times higher than that for boys.
Most of the children were receiving treatment from pediatricians. There is some
evidence that black children with ADHD are not given appropriate levels of
attention compared with that received by white children.[7] Zito and colleagues[7] looked at Medicaid
prescription patterns in Maryland for youths aged 5-14 years. The rate of
prescriptions for black children was half that of white children. The disparity
was greatest for the stimulant medications, with black:white prescription
ratios ranging from 1:2 to 1:2.5, depending on geographic location. There is no
evidence, however, that the prevalence of ADHD is higher among white children.
Bussing and colleagues[7] also found that service delivery to blacks was deficient;
other predictors of unmet service needs in this study included lower income and
HMO coverage.Other researchers have not confirmed racial discrepancies,
however. Kelleher and colleagues[8] found that among a
sample of 14,910 children aged 4-15 years in 44 states, only 57% of psychiatric
disorders were correctly identified. In contrast to the Medicaid prescription
data, there was no variation in identification rates between black and white
children. Similarly, Wasserman and colleagues[9] found no racial
discrepancy in the incidence of symptoms of attention and hyperactivity in a
primary care practice.Steps to Effective Treatment
Presented below is a multistep process
that takes place before the child is actually referred for treatment, and the
treatment process may break down at any step along the way. 1. Display of
problematic behavior. 2. Recognition of the behavior as problematic. The
threshold for recognition of the problem varies widely. Factors such as
cultural acceptance of the behaviors and parental perceptions and tolerance
strongly influence the threshold for referral. The clinical presentation of the
child also influences the tendency to identify a behavior as problematic.
Hyperactivity, for example, tends to be more commonly seen in boys with ADHD
than girls with ADHD.[10] Since hyperactivity
is difficult to deal with in a social setting, it is more likely to be
identified as abnormal.3. Decision to seek an evaluation. A caregiver
may decide that the problem is not of sufficient severity to warrant clinical
interventions. Other barriers at this step are problems, such as, difficulty
finding transportation, payment or insurance difficulties, or perceptions about
the worthiness of the treatment, that may play a significant role in
forestalling the treatment process.4. Correct diagnosis of the ADHD
syndrome. This step is dependent on clinician skill and familiarity with
the diagnostic syndrome. Most children with ADHD are treated by primary care
physicians and neurologists[11] and the diagnostic acumen of nonpsychiatrists varies widely.
5. Initiation of treatment. Although the correct diagnosis may be made,
the family might object to the treatment recommendations. For example, there
may be resistance to the use of medications. Other factors, such as problems in
the therapeutic relationship or cultural differences, may also factor into
treatment acceptance.A Study of Barriers to Help-Seeking and Treatment for ADHD
Bussing[5]
discussed her current study that focuses on the identification of the steps
along the path to treatment that are most likely to result in an inadequate treatment
course. The areas examined most closely included the effect of gender and race
on the referral process as well as the delineation of barriers to treatment
identified by parents.MethodsThe study targeted public school children in
kindergarten to fifth grade. Children with autism or mental retardation were
excluded. In order to identify children at high risk for ADHD, a random phone
survey of 1615 parents was conducted; 79% cooperated. Ninety-six percent of the
participating families allowed for the teacher to be questioned. The average
age of children was 7.8 years. Whites made up 69% of the sample and blacks
comprised 31%. Since the rate of ADHD is higher among boys, a larger number of
girls (67% of the screening sample) was screened to equalize the high-risk
samples subsequently chosen from the screened group. Children were considered
at high risk if either parent or school official recognized that something was
wrong on a variety of scales.Three hundred eighty-nine high-risk children were
identified. The number of boys (52%) was approximately equal to the number of
girls (48%). About one fourth of the sample was receiving special education
services. There were 91 children who met criteria for ADHD yet were untreated
for this disorder. These children fell into the "unmet needs"
category. ResultsDespite the concerns that "something might be wrong"
by either parent or teacher, only 57% of boys and 20% of girls had been
referred for evaluation. Of the entire sample with ADHD, the rates of accurate
diagnosis were 47% for boys and 15% for girls. The rates of ongoing treatment
were 35% for boys and a mere 9% for girls. With respect to race, 28% of the
high-risk black children had been evaluated compared with 51% of white
children; rates of diagnosis were 20% for blacks and 44% for whites. The
eventual treatment rates were 15% for black children and 31% for white
children. A multivariate analysis assessed the extent to which each factor
contributed to the referral and treatment process. Despite the fact that both
boys and girls had approximately an equally high number of symptoms, boys were
nearly 6 times as likely to be referred for the evaluation (odds ratio [OR],
5.8). Children with regular pediatric care were much more likely to be referred
for evaluation (OR, 6.9). White children were nearly 3 times as likely to be
referred for evaluation as were black children. When a summary score of the
parents' overall knowledge was included in the variables, however, the
differences for ethnicity were no longer present; the gender differences
remained however. The parents who did not seek out treatment for their child
were administered a questionnaire assessing for the presence and nature of
barriers to treatment. Twenty barriers were identified and the average number of
barriers endorsed was 4.1. The barriers were grouped as follows:
Lack of perceived need (66% of respondents). Included were statements
such as "My child just got better by herself" or "My child
solved his own problems."
System barriers (53% of respondents). Included were difficulties such as
lack of suitable services, inconvenient location, or language barriers.
Negative expectations (45% of respondents). Concerns were voiced that
the child would be taken away or that treatment would not help. Black parents
endorsed these items more frequently compared with white parents (58% vs 34%).
Stigma (39% of the respondents). Included were concerns by the patient
or family about what others might think. There was significantly more concern
among parents of girls (52%) vs boys (30%).
Financial (39% of the respondents). Expressed concerns about the cost of
treatment, which includes the length or number of visits, cost of medications,
and the issues of reimbursement by insurance companies.Use of Focus GroupsFocus
groups were formed to allow parents to discuss their concerns in a group
setting. The use of these groups has been previously described in Bussing and
Gary (2001).[12] There was a general and consistent concern about the use of
medications, especially stimulant medications such as Ritalin
(methylphenidate). There were also concerns about the ability to get adequate
testing, obtain test results, and the general lack of communication, although
these concerns were more common among whites. Blacks were more likely to cite a
lack of trust in the mental health system and transportation problems. Parents
often explained away girls' behaviors as a phase. They were sometimes described
as "tomboys," and it was thought that they would grow out of this
behavior with time. When ADHD was present in a brother and a sister, it was not
uncommon for the son to get more attention concerning the
behaviors.ConclusionsBussing and colleagues concluded:
There are significantly greater barriers for girls, blacks, and poorer
individuals at multiple levels, including obtaining evaluations by parents,
making the diagnosis by the provider, and obtaining treatment.
The parental decision to seek professional help is the greatest barrier to
treatment
For girls, parental and provider stereotypes of "normal" behavior or
comparisons with male siblings may constitute a significant barrier.
Lower overall parental knowledge concerning ADHD among black parents may play
an important role in delaying or avoiding diagnosis and treatment. Educational
initiatives are needed to improve overall detection and treatment rates for
ADHD. Although there are deficiencies in the treatment process for all
children, the results of this study indicate that particular attention must be
paid to gender and cultural differences. These educational programs need to be
directed toward parents, school officials, and clinicians and physicians in
order to most effectively implement more constructive treatment initiatives.References
Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle
AE.Attention-deficit/hyperactivity disorder in adults: an overview. Biol
Psychiatry. 2000;48:9-20.
Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental
coordination disorder at age 22 years: a controlled, longitudinal,
community-based study. Am Acad Child Adolesc Psychiatry. 2000;39:1424-1431.
Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts
compound in adults with attention-deficit/hyperactivity disorder. Arch Gen
Psychiatry. 2001;58:775-782.
Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of
bupropion for attention deficit hyperactivity disorder in adults. Am J
Psychiatry. 2001;158:282-288.
Bussing R. Barriers to help-seeking and treatment for ADHD. Program and abstracts
of the American Psychiatric Association 53rd Institute on Psychiatric Services;
October 10-14, 2001; Orlando, Florida. Lecture 13.
Bussing R, Zima BT, Perwien AR, Belin TR, Widawski M. Children in special
education programs: attention deficit hyperactivity disorder, use of services,
and unmet needs. Am J Public Health. 1998;88:880-886.
Zito JM, Safer DJ, dosReis S, Riddle MA. Racial disparity in psychotropic
medications prescribed for youths with Medicaid insurance in Maryland. J Am
Acad Child Adolesc Psychiatry. 1998;37:179-184.
Kelleher KJ, Moore CD, Childs GE, et al. Patient race and ethnicity in primary
care management of child behavior problems: a report from PROS and ASPN.
Pediatric research in office settings. Ambulatory Sentinel Practice Network.
Med Care.1999;37:1092-1104.
Wasserman RC, Kelleher KJ, Bocian A, et al. Identification of attentional and
hyperactivity problems in primary care: a report from pediatric research in
office settings and the ambulatory sentinel practice network. Pediatrics.
1999;103:E38.
Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical
review. J Am Acad Child Adolesc Psychiatry. 1997;36:1783.
Zarin DA, Suarez AP, Pincus HA, Kupersanin E, Zito JM. Clinical and treatment
characteristics of children with attention-deficit/hyperactivity disorder in
psychiatric practice. J Am Acad Child Adolesc Psychiatry. 1998;37:1262-1270.
Bussing R, Gary FA. Practice guidelines and parental ADHD treatment
evaluations: friends or foes? Harv Rev Psychiatry. 2001;9:223-233.
http://www.medscape.com/Medscape/CNO/2001/apaips/Story.cfm?story_id=2519
******************************
Major Stress During Pregnancy Linked To Autism
Library: MED
Keywords: AUTISM PRENATAL STRESS PREGNANCY
Description: Women who have had a major stressful event - death of a
spouse, job loss, or a long-distance move - midway through their pregnancy may
have a greater chance of having an autistic child than do their unstressed
counterparts, according to a new study.
![]()
Contact:
Jill Boatman, Medical Center Communications, 614-293-3737, or boatman-2@medctr.osu.edu
MAJOR STRESS DURING PREGNANCY LINKED TO AUTISM
COLUMBUS, Ohio - Women who have had a major stressful event - death of a
spouse, job loss, or a long-distance move - midway through their pregnancy may
have a greater chance of having an autistic child than do their unstressed counterparts
say researchers at Ohio State University Medical Center.
In a presentation at the annual meeting of the Society for Neuroscience in San
Diego, Dr. David Beversdorf, a neurologist at OSU Medical Center and principal
investigator of the study, reported on a study of 188 women who had delivered
autistic children. The research showed that these women were more likely to
have experienced a major stressor the 24th through 28th weeks of their
pregnancy.
"Researchers have been examining the genetic component of the disease for
years, but there is now evidence through this study that autism is also linked
to external factors, such as prenatal stress," he said.
Beversdorf and his collegues asked mothers to document their stress levels when
stressful events occurred during their pregnancies. The study included the
mothers of autistic children, 212 women who had normal births and 92 women who
had children with Down's syndrome - a genetically caused neurological disorder
caused by chromosomal abnormality.
The researchers then used a standard psychological measure - The Social
Readjustment Rating Scale - to gauge the impact at four-week intervals that
those stressors had on the women.
For the study, a "major stressor" was defined as a life-altering
event in the woman's life, such a loss of a loved one or losing a job.
He noted that the numbers of women experiencing major stress during any certain
four-week period in their pregnancies remained fairly constant during the study
for normal and Down's syndrome pregnancies. Stress levels for the mothers of
autistic children were nearly twice those of other mothers in the study.
"We expected that a woman who has had an autistic child or a child with
Down's syndrome would tend to remember these life stressors more easily than a
woman who has had a normal birth," he said.
"What we were looking for was this rise in the numbers of who had a major
stressor during this time period (before 32 weeks) and that these women also
had autistic children."
Beversdorf and his colleagues believe their research supports earlier animal
studies that suggest stress during specific periods in the pregnancy may lead
to structural changes in the brain that have been linked to autism.
The timing of the stressful events recorded for the study seem to mesh well,
timewise, with the periods of development of the fetal cerebellum - a key
portion of the brain that is structurally different in autistic children.
Autism is a neurological disorder that tends to appear early in a child's life,
typically before age 3. These children have problems interacting and
communicating with others, have a language delay, and develop a narrow and
repetitive pattern of behaviors. These behaviors typically stay with the child
throughout his or her life.
"With this information there will be other studies that can hopefully
determine what are the causes and influences of autism in children," said
Beversdorf.
http://www.newswise.com/articles/2001/11/AUTISM.OSU.html
******************************
Psychotropic prescribing practices of paediatricians in the
UK
F McNicholas1 if(version() Bloomfield and Newcomen Centres,
Guy’s Hospital, London, UK
AbstractObjective This study examines
the prescribing practices and attitudes to psychotropic medication by
paediatricians in the UK.Design Questionnaires were sent to 100
randomly chosen paediatricians in the UK to assess their prescribing practices
of psychotropic medication in children.Results Paediatricians see and
treat many children with a wide variety of psychotropic medications on a
regular basis. However, few of them feel competent, and most requested regular
psychopharmacology seminars.Conclusions In the US, primary care
physicians and paediatricians are recognized as primarily responsible for the
continuing increase in psychotropic prescriptions in children. This study shows
that, in the UK, paediatricians also contribute to such prescribing and need to
be taken into account when estimating the prevalence and appropriateness of
such medication use in children.
http://www.blackwellsynergy.com/Journals/content/abstracts/cch/2001/27/6/abstract_cch231.asp?journal=cch&issueid=7779&artid=141609&cid=cch.2001.6&ftype=abstracts
******************************
Melatonin May Treat Side Effects of Antipsychotics
NEW YORK (Reuters
Health) - New study findings suggest that melatonin could help ease the side
effects of drugs used to treat schizophrenia.These drugs, known as
antipsychotics, produce a set of symptoms called tardive dyskinesia (TD), which
include involuntary movements of the limbs and face, tremors and stiffness.
There is currently no treatment for TD.``To our knowledge, this is the first
study to demonstrate clinically meaningful improvement of TD symptoms with
melatonin,'' study lead author Dr. Eyal Shamir of Abarbanel Mental Health
Center in Israel and his colleagues write in the November issue of the Archives
of General Psychiatry. Melatonin is a hormone produced by the brain's pineal
gland. Because it is released into the bloodstream at night, the hormone is
thought to play a role in regulating sleep.Schizophrenia, which affects 1% of
the population, usually strikes in young adulthood, causing disordered thinking
and behavior.With medication, therapy and rehabilitation, many people with
schizophrenia can live relatively normal lives, holding down a job and living
independently, experts agree. Yet the side effects associated with
antipsychotics cause many patients--as many as 40%--to stop taking the drugs,
according to a recent report in The New England Journal of Medicine (news - web
sites).To investigate melatonin as a potential TD treatment, Shamir and
colleagues studied 22 patients with schizophrenia. About half received 10
milligrams of melatonin daily for 6 weeks, followed by another 6 weeks of
treatment with an inactive placebo drug. The other half were treated with the
inactive drug first, followed by melatonin. All patients had a 4-week ``washout
period,'' or break, between treatments.Overall, the study participants
exhibited less severe symptoms after they were treated with melatonin in
comparison to after they received the inactive therapy, the investigators
report. This finding remained true regardless of whether the patients were
first treated with melatonin or the placebo.What's more, seven people showed a
more than 3-point reduction in TD symptom severity--a clinically significant
improvement. Nine patients had a 30% or greater improvement in their symptoms
after melatonin treatment, the report indicates.``It remains to be studied
whether the efficacy of melatonin will further increase with longer treatment
or with larger doses of the hormone,'' the researchers comment.The exact
mechanism of action for melatonin is not known, but Shamir's team speculates
that it may be related to melatonin's powerful antioxidant properties, which
have been shown to have a protective effect on nerve cells.In a related
editorial, Dr. William M. Glazer of Massachusetts General Hospital and his
colleagues write that melatonin may be suppressing TD symptoms instead of
treating them, based on its proposed mechanism of action. They further point
out that the 30% or more reduction in symptom severity is ''relatively weak,''
considering the 50% or more reduction in symptom severity required before a
treatment is assumed effective.``From our perspective, the treatment value of
melatonin for TD is questionable,'' the editorialists write.They add, however,
that the hormone should not be ignored. ''Although the newer-generation
antipsychotic agents may be diminishing the concern about TD, there remain
other safety concerns with these agents that might be helped with antioxidants
and other 'alternative' therapies,'' Glazer's team concludes.SOURCE: Archives
of General Psychiatry 2001;58:1049-1052, 1054-1055.
http://dailynews.yahoo.com/h/nm/20011121/hl/malatonin_1.html
******************************
Autism Awakening, Autism FIrst Steps Newsletter, or any staff do not
endorse any individuals, groups or programs. References regarding
programs, meetings, resources, research, opinions, treatment, etc., should not
be interpreted as an indication of endorsement. They are provided for
informational purposes only. This is an attempt to keep the nation advised to
all diagnostic, treatment, therapy, educational,
options available as well as legislative autism updates and more.
To View
Newsletter Policies they are located at the Newsletter
Website:
Direct Link:: Autism
First Steps Newsletter
http://autismawakeninginia.bizland.com/autismfirststepsnewsletter/
To have
friends, Family, or professionals join:
1. they can go to the above link
2. They can go to the Newsletter Group page located at:
Direct Link::
Yahoo!
Groups : AutismFirstStepsAutismNewsletter
http://groups.yahoo.com/group/AutismFirstStepsAutismNewsletter
3 Send a e-mail to AutismAwakening@aol.com and ask to be subscribed to
the free online daily newsletter
Visit one of the largest websites Commited to bringing you the latest in news,
options, and techniques, and more on Autism located at:
Direct Link:: Autism Awakening 4 Kids
www.AutismAwakening.com
To Submit a
story, alert, readers post, or advertisement please e-mail AutismAwakening@aol.com
To be removed reply to this e-mail and requested to be removed from the list.
ALL INFORMATION,
DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL
INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.